Gene therapy for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is characterized by the selective loss of neurons responsible for controlling the skeletal muscles. Neuregulin type 1 (NRG1) contributes to compensating this loss in general, but this mechanism is altered in patients with ALS. To restore this...